Lamotrigin Acis

Lamotrigine, the active ingredient in Lamotrigin Acis, is an anticonvulsant presented as an oral tablet for oral use. It treats epilepsy, including partial and generalized tonic‑clonic seizures, and serves as maintenance therapy for bipolar disorder in adults and children.

GNH USA supplies Lamotrigin Acis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable global distribution. Our network ensures timely delivery and regulatory compliance across multiple regions.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

- Partial seizures: reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with epilepsy. - Bipolar disorder (maintenance): stabilizes mood and lowers risk of relapse in bipolar I patients.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior

When prescribing Lamotrigin Acis, several safety considerations are recommended.

- Pregnancy: safety not established; discuss risks with prescriber. - Renal impairment: dose may require adjustment; monitor renal function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant valproic acid: may increase lamotrigine levels; increase risk of toxicity. - Avoid abrupt discontinuation: may precipitate seizure recurrence. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Lamotrigin Acis interacts with several medicines; awareness helps avoid therapeutic failure or toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine plasma concentrations, raising toxicity risk. - Carbamazepine, phenytoin, phenobarbital: induce metabolism, reducing lamotrigine levels and efficacy. - Oral contraceptives: lower lamotrigine concentrations; may require dose adjustment.

Moderate Interactions (Monitor Closely): - Serotonergic agents (SSRIs, MAOIs): potential for serotonin syndrome. - Other antiepileptic drugs (e.g., topiramate): may alter lamotrigine levels. - Alcohol: can enhance central nervous system depression.